This is a notice to let potential applicants know that a new fund will be administered by Cy Pres Settlement Funds in 2022, stemming from the settlement that has been reached regarding the prescription drugs PROVIGIL®, NUVIGIL®, and generic PROVIGIL® (modafinil). The Settlement resolves Defendants’ alleged violations of antitrust and consumer protection laws by delaying the availability of less expensive generic versions of Provigil®. The Defendants have denied any wrongdoing and no one is claiming that these drugs are unsafe or ineffective.
The press release from the California Attorney General’s Office can be viewed here:
Details will be forthcoming once the California Attorney General’s Office has paid out all consumer claims and a final residual amount has been established, which will be the basis for cy pres grantmaking to benefit the injured consumer class.